Literature DB >> 23401727

Prostaglandin e1 on infradiaphragmatic type of total anomalous pulmonary venous connection - a case report.

Catalin Cirstoveanu1, Eliza Cinteza, Veronica Marcu, Mihaela Bizubac, Alina Balomir, Ileana Barascu, Mariana Coman, Mihaela Balgradean.   

Abstract

We present the case of a newborn with severe pulmonary hypertension, diagnosed with infradiaphragmatic type of total anomalous pulmonary venous connection (TAPVC). The onset was in the first 10 days of life. Diagnosis was made by echocardiography and AngioCT. The pulmonary venous collector was surgically implanted into the left atrium in Germany, but the next month after surgery he developed cardiopulmonary insufficiency and died several days later. We would like to emphasize the importance of prostaglandin E1 administration in this particular case of infradiaphragmatic type of TAPVC and its usefulness in patient's stabilization until surgery. The prognosis in TAPVC, infradiaphragmatic type, is poor and is related mainly to the existence of pulmonary venous obstruction.

Entities:  

Year:  2012        PMID: 23401727      PMCID: PMC3557426     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  12 in total

1.  Pulmonary vein stenosis following repair of total anomalous pulmonary venous connection.

Authors:  Eric J Devaney; Richard G Ohye; Edward L Bove
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2006

Review 2.  Obstructive total anomalous pulmonary venous drainage.

Authors:  A Nabar; B Dalvi
Journal:  Indian J Pediatr       Date:  1998 Jan-Feb       Impact factor: 1.967

3.  Total anomalous pulmonary venous connection to portal system: a new therapeutic role for prostaglandin E1?

Authors:  C A Bullaboy; D H Johnson; H Azar; R B Jennings
Journal:  Pediatr Cardiol       Date:  1984 Apr-Jun       Impact factor: 1.655

4.  Early and long-term results for correction of total anomalous pulmonary venous drainage (TAPVD) in neonates and infants.

Authors:  N Sinzobahamvya; C Arenz; A M Brecher; H C Blaschczok; A E Urban
Journal:  Eur J Cardiothorac Surg       Date:  1996       Impact factor: 4.191

5.  Management of pulmonary venous obstruction after correction of TAPVC: risk factors for adverse outcome.

Authors:  M Ricci; M Elliott; G A Cohen; G Catalan; J Stark; M R de Leval; V T Tsang
Journal:  Eur J Cardiothorac Surg       Date:  2003-07       Impact factor: 4.191

6.  Total anomalous pulmonary venous return with the circular pulmonary venous connection: outcome of common pulmonary venous agenesis.

Authors:  M Kitano; K Watanabe; T Yagihara; S Echigo
Journal:  Pediatr Cardiol       Date:  2004 Jul-Aug       Impact factor: 1.655

7.  Preoperative pulmonary venous obstruction affects long-term outcome for survivors of total anomalous pulmonary venous connection repair.

Authors:  Paul M Kirshbom; Richard J Myung; J William Gaynor; Richard F Ittenbach; Stephen M Paridon; William M DeCampli; Tom R Karl; Thomas L Spray
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

8.  Prostaglandin E1 opens the ductus venosus in the newborn lamb.

Authors:  F C Morin
Journal:  Pediatr Res       Date:  1987-03       Impact factor: 3.756

9.  Pulmonary vein and atrial wall pathology in human total anomalous pulmonary venous connection.

Authors:  Yvonne L Douglas; Monique R M Jongbloed; Wietske C E den Hartog; Margot M Bartelings; Ad J J C Bogers; Tjark Ebels; Marco C DeRuiter; Adriana C Gittenberger-de Groot
Journal:  Int J Cardiol       Date:  2008-12-30       Impact factor: 4.164

10.  Total anomalous pulmonary venous return: familial and environmental factors. The Baltimore-Washington Infant Study Group.

Authors:  A Correa-Villaseñor; C Ferencz; J A Boughman; C A Neill
Journal:  Teratology       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.